Kevin M Arnold
Overview
Explore the profile of Kevin M Arnold including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
253
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Albaugh B, Arnold K, Lee S, Denu J
J Biol Chem
. 2011 May;
286(28):24694-701.
PMID: 21606491
Rtt109 is a yeast histone acetyltransferase (HAT) that associates with histone chaperones Asf1 and Vps75 to acetylate H3K56, H3K9, and H3K27 and is important in DNA replication and maintaining genomic...
2.
Albaugh B, Arnold K, Denu J
Chembiochem
. 2011 Jan;
12(2):290-8.
PMID: 21243716
Post-translational modifications of histones elicit structural and functional changes within chromatin that regulate various epigenetic processes. Epigenetic mechanisms rely on enzymes whose activities are driven by coenzymes and metabolites from...
3.
Arnold K, Lee S, Denu J
Biochemistry
. 2010 Dec;
50(5):727-37.
PMID: 21182309
Esa1, an essential MYST histone acetyltransferase found in the yeast piccolo NuA4 complex (picNuA4), is responsible for genome-wide histone H4 and histone H2A acetylation. picNuA4 uniquely catalyzes the rapid tetra-acetylation...
4.
Kolonko E, Albaugh B, Lindner S, Chen Y, Satyshur K, Arnold K, et al.
Proc Natl Acad Sci U S A
. 2010 Nov;
107(47):20275-80.
PMID: 21057107
Most histone acetyltransferases (HATs) function as multisubunit complexes in which accessory proteins regulate substrate specificity and catalytic efficiency. Rtt109 is a particularly interesting example of a HAT whose specificity and...
5.
Kocisko D, Vaillant A, Lee K, Arnold K, Bertholet N, Race R, et al.
Antimicrob Agents Chemother
. 2006 Feb;
50(3):1034-44.
PMID: 16495266
Although transmissible spongiform encephalopathies (TSEs) are incurable, a key therapeutic approach is prevention of conversion of the normal, protease-sensitive form of prion protein (PrP-sen) to the disease-specific protease-resistant form of...
6.
Moore R, Herzog C, Errett J, Kocisko D, Arnold K, Hayes S, et al.
Protein Sci
. 2006 Feb;
15(3):609-19.
PMID: 16452616
A central feature of transmissible spongiform encephalopathies (TSE or prion diseases) involves the conversion of a normal, protease-sensitive glycoprotein termed prion protein (PrP-sen) into a pro-tease-resistant form, termed PrP-res. The...
7.
Kocisko D, Engel A, Harbuck K, Arnold K, Olsen E, Raymond L, et al.
Neurosci Lett
. 2005 Jul;
388(2):106-11.
PMID: 16039063
The transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases. A primary therapeutic target for TSE intervention has been a protease-resistant form of prion protein known as PrP(Sc) or PrP-res. In...